English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/133928
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program

AuthorsAguilar, Esther; Zodda, Erika; Meca-Cortés, Óscar ; Delowar, Hossain; Pons, Mònica ; Celià-Terrassa, Toni ; Thomson, Timothy M. ; Cascante, Marta
KeywordsMitochondrial metabolism
Metabolic flux analysis
Warburg effect
Epithelial-mesenchymal transition
Cancer stem cells
Issue Date11-Jan-2016
PublisherAlphaMed Press
CitationStem Cells 34(5): 1163-1176 (2016)
AbstractIn solid tumors, cancer stem cells (CSCs) can arise independently of epithelial-mesenchymal transition (EMT). In spite of recent efforts, the metabolic reprogramming associated with CSC phenotypes uncoupled from EMT is poorly understood. Here, by using metabolomic and fluxomic approaches, we identify major metabolic profiles that differentiate metastatic prostate epithelial CSCs (e-CSCs) from non-CSCs expressing a stable EMT. We have found that the e-CSC program in our cellular model is characterized by a high plasticity in energy substrate metabolism, including an enhanced Warburg effect, a greater carbon and energy source flexibility driven by fatty acids and amino acid metabolism and an essential reliance on the proton buffering capacity conferred by glutamine metabolism. An analysis of transcriptomic data yielded a metabolic gene signature for our e-CSCs consistent with the metabolomics and fluxomics analyses that correlated with tumor progression and metastasis in prostate cancer and in 11 additional cancer types. Interestingly, an integrated metabolomics, fluxomics, and transcriptomics analysis allowed us to identify key metabolic players regulated at the post-transcriptional level, suggesting potential biomarkers and therapeutic targets to effectively forestall metastasis.
DescriptionEsther Aguilar et al.
Publisher version (URL)http://dx.doi.org/10.1002/stem.2286
Identifiersdoi: 10.1002/stem.2286
issn: 1549-4918
Appears in Collections:(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.